A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B
1. 系统已在2026-03-11 15:11:55对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1111/j.1365-2516.2010.02470.x
文献链接: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2010.02470.x
其他信息:
出版社: Wiley
作者: T. LISSITCHKOV; M. MATYSIAK; K. ZAVILSKA; P. ŁAGUNA; L. GERCHEVA; A. ANTONOV; N. CABRERA; J. A. AZNAR; M. K. WOODWARD; A. PÁEZ

